SwitchPoint Bio Holding, Inc. — Form D
SwitchPoint Bio Holding, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-10. The offering totals $5.3M, of which $5.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-10
- Form: D
- Accession: 0002113353-26-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $5.3M
- Amount sold: $5.3M
- Investors: 6
- Date of first sale: 2026-03-09
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-576064
Issuer
- Name: SwitchPoint Bio Holding, Inc.
- CIK: 0002113353
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 251 LITTLE FALLS DRIVE, WILMINGTON, DE, 19808
- Phone: 6509969693
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Samuel Myllykangas | Director | Espoo, H9 |
| Jussi Paananen | Director | Helsinki, H9 |
| David Proctor | Director | Austin, TX |
| Samuel Myllykangas | Executive Officer | Espoo, H9 |
| Jussi Paananen | Executive Officer | Helsinki, H9 |
More